Daxor Total Stockholder Equity from 2010 to 2025

DXR Stock  USD 7.74  0.38  5.16%   
Daxor Total Stockholder Equity yearly trend continues to be relatively stable with very little volatility. Total Stockholder Equity is likely to drop to about 31.3 M. Total Stockholder Equity is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. View All Fundamentals
 
Total Stockholder Equity  
First Reported
1985-12-31
Previous Quarter
32.7 M
Current Value
32.7 M
Quarterly Volatility
11.4 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Daxor financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Daxor's main balance sheet or income statement drivers, such as Depreciation And Amortization of 612 K, Interest Expense of 66.3 K or Selling General Administrative of 335.8 K, as well as many indicators such as Price To Sales Ratio of 329, Dividend Yield of 0.0074 or PTB Ratio of 1.33. Daxor financial statements analysis is a perfect complement when working with Daxor Valuation or Volatility modules.
  
Check out the analysis of Daxor Correlation against competitors.
To learn how to invest in Daxor Stock, please use our How to Invest in Daxor guide.

Latest Daxor's Total Stockholder Equity Growth Pattern

Below is the plot of the Total Stockholder Equity of Daxor over the last few years. It is the total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Daxor's Total Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Daxor's overall financial position and show how it may be relating to other accounts over time.
Total Stockholder Equity10 Years Trend
Pretty Stable
   Total Stockholder Equity   
       Timeline  

Daxor Total Stockholder Equity Regression Statistics

Arithmetic Mean23,402,310
Geometric Mean21,515,096
Coefficient Of Variation41.34
Mean Deviation8,554,180
Median24,580,735
Standard Deviation9,674,464
Sample Variance93.6T
Range26.5M
R-Value0.22
Mean Square Error95.5T
R-Squared0.05
Significance0.41
Slope445,400
Total Sum of Squares1403.9T

Daxor Total Stockholder Equity History

202531.3 M
202439.1 M
202334 M
202229 M
202121.2 M
202015.7 M
201912.8 M

About Daxor Financial Statements

Daxor shareholders use historical fundamental indicators, such as Total Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Daxor investors may analyze each financial statement separately, they are all interrelated. The changes in Daxor's assets and liabilities, for example, are also reflected in the revenues and expenses on on Daxor's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Stockholder Equity39.1 M31.3 M

Pair Trading with Daxor

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Daxor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daxor will appreciate offsetting losses from the drop in the long position's value.

Moving together with Daxor Stock

  0.67CI Cigna CorpPairCorr
  0.78COO Cooper Companies,PairCorr

Moving against Daxor Stock

  0.62ANGO AngioDynamicsPairCorr
  0.44IDXX IDEXX LaboratoriesPairCorr
The ability to find closely correlated positions to Daxor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Daxor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Daxor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Daxor to buy it.
The correlation of Daxor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Daxor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Daxor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Daxor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Daxor Stock Analysis

When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.